Rezultati - David V. Erbe

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
    Reduction in urinary oxalate excretion in mouse models of Primary Hyperoxaluria by RNA interference inhibition of liver lactate dehydrogenase activity

    Reduction in urinary oxalate excretion in mouse models of Primary Hyperoxaluria by RNA interference inhibition of liver lactate dehydrogenase activity od Kyle D. Wood, Ross P. Holmes, David V. Erbe, Abigail Liebow, Sonia Fargue, John Knight

    Izdano 2019
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  2. 2
    An Investigational RNAi Therapeutic Targeting Glycolate Oxidase Reduces Oxalate Production in Models of Primary Hyperoxaluria

    An Investigational RNAi Therapeutic Targeting Glycolate Oxidase Reduces Oxalate Production in Models of Primary Hyperoxaluria od Abigail Liebow, Xingsheng Li, Timothy Racie, Julia Hettinger, Brian R. Bettencourt, Nader Najafian, Patrick Haslett, Kevin Fitzgerald, Ross P. Holmes, David V. Erbe, William Querbes, John Knight

    Izdano 2016
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  3. 3
    Neurofilament Light Chain as a Biomarker of Hereditary Transthyretin-Mediated Amyloidosis

    Neurofilament Light Chain as a Biomarker of Hereditary Transthyretin-Mediated Amyloidosis od Simina Ticau, Gautham Sridharan, Shira Tsour, William Cantley, Amy Chan, Jason A. Gilbert, David V. Erbe, Emre Aldinc, Mary M. Reilly, David Adams, Michael Polydefkis, Kevin Fitzgerald, Akshay Vaishnaw, Paul Nioi

    Izdano 2020
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  4. 4
    A zymogen-like factor Xa variant corrects the coagulation defect in hemophilia

    A zymogen-like factor Xa variant corrects the coagulation defect in hemophilia od Lacramioara Ivanciu, Raffaella Toso, Paris Margaritis, Giulia Pavani, Haein Kim, Alexander Schlachterman, Jianhua Liu, Valérie Clerin, Debra D. Pittman, Rosalind Rose-Miranda, Kathleen Shields, David V. Erbe, James F. Tobin, Valder R. Arruda, Rodney M. Camire

    Izdano 2011
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  5. 5
    Crystal Structure of an HSA/FcRn Complex Reveals Recycling by Competitive Mimicry of HSA Ligands at a pH-Dependent Hydrophobic Interface

    Crystal Structure of an HSA/FcRn Complex Reveals Recycling by Competitive Mimicry of HSA Ligands at a pH-Dependent Hydrophobic Interface od Michael M. Schmidt, Sharon A. Townson, Amy Andreucci, Bracken M. King, Emily B. Schirmer, Alec Murillo, Christian Dombrowski, Alison W. Tisdale, Patricia Lowden, Allyson Masci, Joseph Kovalchin, David V. Erbe, K. Dane Wittrup, Eric S. Furfine, Thomas M. Barnes

    Izdano 2013
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  6. 6
    Phase 1/2 Study of Lumasiran for Treatment of Primary Hyperoxaluria Type 1

    Phase 1/2 Study of Lumasiran for Treatment of Primary Hyperoxaluria Type 1 od Yaacov Frishberg, Georges Deschênes, Jaap W. Groothoff, Sally‐Anne Hulton, Daniella Magen, Jérôme Harambat, William G. van’t Hoff, Ulrike Lorch, Dawn S. Milliner, John C. Lieske, Patrick Haslett, Pushkal Garg, Akshay Vaishnaw, Sandeep Talamudupula, Jiandong Lu, Bahru Habtemariam, David V. Erbe, Tracy L. McGregor, Pierre Cochat

    Izdano 2021
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  7. 7
    Characterising a healthy adult with a rare HAO1 knockout to support a therapeutic strategy for primary hyperoxaluria

    Characterising a healthy adult with a rare HAO1 knockout to support a therapeutic strategy for primary hyperoxaluria od Tracy L. McGregor, Karen A. Hunt, Elaine Yee, Dan Mason, Paul Nioi, Simina Ticau, Marissa Pelosi, Perry R Loken, Sarah Finer, Debbie A. Lawlor, Eric B. Fauman, Qin Qin Huang, Chris Griffiths, Daniel G. MacArthur, Richard C. Trembath, Devin Oglesbee, John C. Lieske, David V. Erbe, John Wright, David A. van Heel

    Izdano 2020
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  8. 8
    Scaffold-based discovery of indeglitazar, a PPAR pan-active anti-diabetic agent

    Scaffold-based discovery of indeglitazar, a PPAR pan-active anti-diabetic agent od Dean R. Artis, Jack J. Lin, Chao Zhang, Weiru Wang, Upasana Mehra, Mylène Perreault, David V. Erbe, Heike I. Krupka, B.P. England, J. Malcolm O. Arnold, A.N. Plotnikov, Adhirai Marimuthu, Hoa Nguyen, Sarah Will, Maxime Signaevsky, John G. Kral, John Cantwell, Calvin Settachatgull, Douglas S. Yan, Daniel W. Fong, Angela J. Oh, Shenghua Shi, Patrick Womack, Benjamin E. Powell, Gaston Habets, Brian L. West, Kam Y. J. Zhang, Michael V. Milburn, George P. Vlasuk, K. Peter Hirth, K. B. Nolop, Gideon Bollag, Prabha N. Ibrahim, James F. Tobin

    Izdano 2008
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:

Iskalna orodja: